DSOL (Drug Free Solution) EBITDA Margin %: 0.00% (As of Feb. 2014)


What is Drug Free Solution EBITDA Margin %?

Drug Free Solution DSOL EBITDA Margin % is 0.00% as of Feb. 2014.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Drug Free Solution's EBITDA for the three months ended in Feb. 2014 was $-0.12 Mil. Drug Free Solution's Revenue for the three months ended in Feb. 2014 was $0.00 Mil. Therefore, Drug Free Solution's EBITDA margin for the quarter that ended in Feb. 2014 was 0.00%.

Drug Free Solution  (OTCPK:DSOL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Drug Free Solution EBITDA Margin % Related Terms

Drug Free Solution EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Drug Free Solution's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drug Free Solution EBITDA Margin % Chart

Drug Free Solution Annual Data
Trend May12 May13
EBITDA Margin %
0.00 0.00

Drug Free Solution Quarterly Data
Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -6,150.00 0.00

DSOL vs USEL, ZZLL, WSCO: EBITDA Margin % Comparison

For the Health Information Services subindustry, Drug Free Solution's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Drug Free Solution EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Drug Free Solution's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Drug Free Solution's EBITDA Margin % falls into.


Drug Free Solution EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Drug Free Solution's EBITDA Margin % for the fiscal year that ended in May. 2013 is calculated as

EBITDA Margin %=EBITDA (A: May. 2013 )/Revenue (A: May. 2013 )
=-0.755/0
= %

Drug Free Solution's EBITDA Margin % for the quarter that ended in Feb. 2014 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2014 )/Revenue (Q: Feb. 2014 )
=-0.117/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Drug Free Solution (DSOL) has a EBITDA Margin % of 0.00% as of Feb. 2014. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Drug Free Solution and its competitors.
Is Drug Free Solution's EBITDA Margin % too high?
Drug Free Solution's current EBITDA Margin % is 0.00%.
How does Drug Free Solution's EBITDA Margin % compare to USEL and ZZLL?
Drug Free Solution's EBITDA Margin % of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Drug Free Solution and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Drug Free Solution's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drug Free Solution stock overvalued right now?
Drug Free Solution (DSOL) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Drug Free Solution (DSOL), the current EBITDA Margin % is 0.00% as of Feb. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drug Free Solution Business Description

Address 2211 Michelson Drive, Irvine, CA, USA, 92612
Drug Free Solution Inc is a United States based holding company that owns and operates various subsidiaries in the healthcare industry. It is focused on acquiring healthcare operations that focus on Home Healthcare, Developmental Disabilities, Hospice Care, Skilled Nursing, Residential Rehabilitation, Home & Community Based Services.